Neuroblastoma: open trials in Norway

• 2023-504880-18-00

  A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies

  Trial Treatment · Phase 1/2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

  St. Olavs hospital HF, Trondheim

  Registry updated 2026-05-07

• NCT07334301

  A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

  Trial Treatment · Phase 1/2 · University of Birmingham

  Oslo University Hospital HF, Oslo

  Registry updated 2026-01-12

• NCT05192980

  SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

  Trial Treatment · Institut Curie

  Oslo Universitetssykehus, Oslo

  Registry updated 2025-07-22

• NCT04221035

  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris

  Haukeland University Hospital, Bergen · Oslo University Hospital HF, Oslo · The University Hospital of North Norway (UNN), Tromsø · St. Olavs hospital HF, Trondheim

  Registry updated 2025-06-26

• NCT04903899

  177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma

  Trial Treatment · Phase 2 · Jakob Stenman

  Helse Bergen HF, Bergen · Oslo University Hospital HF, Oslo

  Registry updated 2025-02-11

All Neuroblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error